Skip to main content

is part of the Informa Markets Division of Informa PLC

  • INFORMA PLC
  • ABOUT US
  • INVESTOR RELATIONS
  • TALENT

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

pharmapackeurope
 
    • Sign-Out
    • My Profile
  • CPhI EVENTS BY REGION
    • China
    • Europe
    • India
    • Japan
    • Korea
    • Middle East
    • North America
    • South East Asia

CPHI ONLINE

1 & 2 February 2023
Paris Expo, Porte de Versailles - Hall 7.2 | Paris, France

 

18 January - 17 February 2023
Online event and networking

Online Event
img-responsive
REGISTER FOR 2023
img-responsive
  • HOME
  • ATTEND
    • Event App
    • Pass Options
    • Hybrid Event
    • Travel Information
    • Register to Attend
    • Visitor FAQ
  • EXHIBITOR LIST
  • EXHIBIT
    • Book Your Stand
    • Exhibit Options
    • Sponsorship Opportunities
    • All Year Round Promotion
    • Floorplan Download
    • Testimonials
    • Exhibitor FAQ
  • INNOVATION
    • Pharmapack Awards
    • Pharmapack Awards Winners
    • Pharmapack Awards Jury
    • Start-up Hub
    • Start-up Package
    • Innovation Gallery
  • CONTENT
    • Speaker Line Up (2023)
    • Webinars On-Demand
    • Pharmapack Europe 2024 - Call For Speakers
    • Conference Theatre
    • Workshops
    • Learning Labs
    • Innovation Tours
  • ABOUT
    • News & Updates
    • COVID-19 Update
    • Our Partners
    • Press
    • Sustainability
    • Contact Us
    • Youtube Channel
  • Home
  • CONTENT
  • Conference Theatre
MISSED PHARMAPACK'S ONLINE CONFERENCE?

Conference Theatre


Market Trends & Thought Leadership

The conference will feature thought-provoking sessions on the latest market trends and updates in the drug delivery and pharma packaging industry. Senior stakeholders from these fields are invited to attend and gain valuable insights from industry experts 


Explore more content

Learning Labs
img-responsive
Workshops
img-responsive
Speaker Line-Up
img-responsive


  • Day 1
  • Day 2

Track: Device & Packaging Innovation

Location (Room-721)

Track Chair: Mayur Patel, Technology Innovation Expert, PA Consulting

 

10:30-11:00 AM | Keynote: Patient Centricity in Small Molecule Development

This session will showcase how synergies between a small molecule formulation team, human factors, and packaging have led to better patient-centric solutions.

In addition, it will touch upon Some of the principles to consider for patient-centric development and well as well as highlight some of Roche's methods for continuous pipeline assessments to understand user needs and assign appropriate resources.

-

Speaker:

Tiffany McIntire, Principal Human Factors Engineer, Roche

 

11:05-11:30 AM | Digital Consumer Trends

This session will touch upon consumer behaviours of smart devices, their adoption and usage while measuring consumer preferences and habits around digital products and services. 

The session will pose questions about which devices people have access to and how often they use them while comparing the trajectory of saturated markets like smartphones with newer markets like voice-assisted speakers and virtual reality headsets. And it speculates on our future relationship with devices amid the economic squeeze.

-Device Adoption & Usage
-Access to them
-Oversaturated & Newer Markets
-Future Ahead

-

Speaker:

Hugo Alexandre Ferreira, Associate Professor, University of Lisbon

 

11:35-12:00 PM | Size Matters? Key Drivers for Consolidation in Pharmaceutical Packaging

- Besides the large multinational players, the pharmaceutical packaging market is still very fragmented

- Packaging companies face increasing size pressure from customers and suppliers- 

- Regulatory and R&D requirements are increasing with a heavily rising cost base

- Are strategic alliances the right answer to these trends?

 

-

Speaker:

Gregor Nischer, Managing Partner, MP Corporate Finance GmbH

12:05-12:30 PM | Building Better Patient Experience

Patients are in need. Yet, patient involvement cannot be overcome by providing a solution that effectively and safely meets a need and is well tolerated. Patients, more concerned than ever with their health, are demanding more of such solutions. In this talk, we'll discover that if your solution meets their expectations in addition to their needs, chances are they will be more engaged with it. When that solution also helps patients to realise one or more life aspirations, the engagement in that solution becomes even more significant. These two building blocks drive customer transformation and ensure greater patient engagement with your healthcare solution.

 

-

Speaker:

Christophe Jauquet, Health Business Expert

12:40-13:30 PM | Innovative Strategies Driving a Patient-Centric E-Culture

- Challenges around patient digital adoption

- The need for user engagement to create meaningful solutions

- The use of digital products to improve patient experience in clinical trials

- Challenges of designing information – the use of eIFUs to create opportunities

- Packaging innovations to improve the patient experience

 

-

Speaker:

Charlotte Harris, Head of Front-End Innovation, Team Consulting

Ben Cox, Head of Digital Design, Team Consulting

Gabriel Lobbi, Group Head Innovation & User Experience, Connected Health Product Development, Novartis

Eva Topole, Clinical Program Leader (respiratory) and Clinical Research Physician, Chiesi

Johanna Weibel, Director, User Centred Design – Global Digital Health, Merk

Track: Large Volume Drug Delivery & Combination Products

Location (Room-721)

Track Chair: Asmita Khanolkar, Senior Director, Cambridge Pharma/Oval, SMC Ltd.

Track Sponsor: BD

14:00-14:30 PM | De-risking combination product development for large volume biologics: a pharma partner’s perspective

Transitioning drugs from IV to subcutaneous (SC) delivery brings new requirements and impacts program considerations for combination product development. In this session, we identify trade-offs that pharma weighs to de-risk combination product development programs involving large volume subcutaneous (LVSC) delivery. Key issues can include: 

- Understanding the patient experience throughout the injection process with large volume subcutaneous delivery.

- Reducing risk of user variability to gain market confidence in successfully delivering LVSC formulations.

- Leveraging partner capabilities, insights, and data to inform combination product trade-offs and program risks.

- Manufacturability of the combination product including the delivery system and integration into the pharmaceutical operations network.

- Exploring the value of drug delivery technology used consistently from clinical development into commercial use. 

- Examples of how these issues can impact a combination product development program may be explored.

 

-

Panelist:

Adam Kalbermatten, Vice President Commercial Development, BD Medical - Pharmaceutical Systems

14:40-15:30 PM | Panel Discussion: Novel Medicines and Greater Demand for Injectable Self-Administration

This session will aim to bring together experts in the industry to discuss the trends around driving self-administration drug delivery systems and expected practices for developing an injectable combination product. Join us in this panel to discuss about:

 

- When is it appropriate to convert conventional injectables into autoinjectors 

- Which are the advantages and disadvantages of pens and autoinjectors for chronic treatments

- eHealth and integration of electronics in medical devices: what is hindering full connectivity in pharma

- Tissue models (in-vitro / ex-vivo) for accelerating autoinjectors development

- Medical treatments in an aging world: how self-administration can improve patient adherence 

- Wearable devices: state-of-the-art and next frontiers

 

-

Panelist:

Iain Simpson, Commercial Director - Platforms and Products, Phillips-Medisize

Mario Maio, Senior CMC Consultant, MM Pharma Consulting

Annie Zavadil, Device Project Leader, Novartis

Gurmeet Singh, Senior Director, Global Business Development, West Pharmaceutical Services

Adam Kalbermatten, Vice President Commercial Development, BD Medical - Pharmaceutical Systems

15:35-16:00 PM | The Advantages of Robotics in Aseptic Fill Finish

This session will highlight how robotic aseptic fill/finish equipment offers the flexibility to adjust to future growth and the speed to market necessary for today's changing industry:

 

- How robotics offers new answers to today's challenges

- Leveraging semi-automated to completely automated and integrated cGMP manufacturing systems for processing vials, syringes and cartridges

- Maintaining aseptic conductions throughout the production process for complex biologic compounds, recombinant proteins and monoclonal antibodies (MAbs)

 

-

Speaker:

Keith Dodson, Vice President of Global Business Development, AST

16:05-16:30 PM | From Concept to Ready for Tooling in Three months: Biosimilars Autoinjector Development

Biosimilar drugs offer cost-effective ground-breaking therapies to ever-expanding markets across the World. Some of these drugs are intended for self-injection using autoinjectors for enhanced usability and patient safety. Developing devices for biosimilars requires a greater focus on the cost of goods and design for manufacturing, in addition to the expected robustness, reliability and safety of a patient-centric device design.

This session will present experiences from an autoinjector development program and how to apply quality-by-design ideas to go from concept to ready for tooling in three months. Finally, we will look at the current biosimilar trends and the use of devices with biosimilars.

-

Speaker:

Charbel Tengroth, CEO, Norrneo AB

16:35-17:00 PM | Usability Engineering for MDR Ready Product Design

Since the introduction of the new MDR, usability engineering has been put into the focus of the lifecycle development. Especially for combination products, submissions to notified bodies require additional usability considerations and efforts.

This session will introduce attendees to important aspects that are required to comply with MDR, IEC 62366 and FDA Human factors guideline from a design and engineering perspective. The user centred design approach, incl risk aspects will also be taken into consideration.

-

Speaker:

Dorothee Weichel, Usability Expert, Helbling Technik Bern AG

Track: Sustainability

Location (Room-721)

Track Chair: Kristien De Clercq, Senior Senior Consultant Mechanical Engineer, Springboard Pro Ltd.

10:30-11:00 AM | Putting ESG into Practice – Decarbonizing Supply Chains in the Pharma Industry

The complexity and risks found within the global pharma supply chain cannot be understated and key stakeholders from customers to regulators and investors are increasingly expecting the industry to both manage ESG risks and embed sustainability throughout the value chain. This can only be achieved through industry-wide collaboration that sets the standard for what a responsible supply chain looks like and provides support to suppliers to achieve these goals. The Pharmaceutical Supply Chain Initiative (PSCI) and our membership of 70+ pharma and healthcare companies are leading this collaboration to create harmonized approaches and frameworks for our value chains. We tackle issues such as environmental sustainability that seek to conserve natural resources, reduce greenhouse gas (GHG) emissions, preserve biodiversity and clean water and minimize and control the use of hazardous materials. A key focus of work is the challenge of decarbonization within the industry and the PSCI’s Decarbonization Maturity Model is a roadmap helping suppliers evaluate their current practices and how they can progress in line wider industry expectations.

 

-

Speaker:

Jose Francisco Vallejo Carrera, Global Head of Environment & Environmental Sustainability Corporate HSE, Sanofi

11:10-12:00 PM |Panel Discussion: Integrating Product Design and Supply Chain Management for a Circular Economy

The pharmaceutical supply chain is complex, and pharmaceutical companies must address the most common challenges to efficiently get patients their needed medications. Despite present challenges, the supply chain is prepared to accommodate drug delivery technology in a new era of patient healthcare. This session will aim to answer some of the most pressing questions:

 

- Does the drug delivery industry need to be more environmentally sustainable?

- How can we or should we measure environmental impact?

- What is the current environmental impact of drug-delivery devices?

- How can we reduce environmental impact through device design?

- How can we increase environmental sustainability through supply chain optimisation?

- What could the future hold for the sustainability of the drug delivery industry?

 

-

Speaker:

Tom Oakley, Director of Drug Delivery Device Development, Springboard

Markus Schönfeld, Project Leader Packaging, Novartis

Claus Jürgen, Global Head of EcoDesign and Circular Economy, Sanofi

Isobel Filipova, Sustainability Lead, Owen Mumford

Julien Tremblin, General Manager Europe, TerraCycle

Nic Hunt, Sustainability Director, Nelipak

12:05-12:30 PM | It's Time to Get Real with Healthcare's Path to Net Zero

Country regulations are swiftly moving to enforce the reporting of the carbon footprint from medicinal products. A large proportion of emissions are generated from packaging and drug delivery devices, two areas that have been identified as strategic focus areas in which clear action can be taken. Healthcare systems are also pushing towards alignment across all suppliers to their net zero commitments. This is a monumental task that has ramifications across the pharmaceutical industry, not least because healthcare is far behind other sectors in understanding its carbon footprint. This session will examine the following:

 

- A review of the pharmaceutical industry’s carbon footprint 

- Investigating the impact from drug delivery devices

- A snapshot of action from companies 

- Recommendations for navigating this change in the following decade

 

-

Speaker:

Aurelio Arias, Engagement Manager, Thought Leadership, IQVIA

12:35-13:00 PM | The potential for Creating a Carbon Handprint? The Role of the Pharmaceutical Industry from “Contributing” to “Tackling” Climate Emergency

The climate crisis is, without a doubt, one of the biggest challenges for the existence of humankind. The Pharma Sector sure has quite some potential in ensuring its footprint becomes much less: The total global emissions of the Pharma Sector amounted to 52 megatonnes of CO2e (2015) – more than the automotive industry in the same year, not speaking of its potential impacts for other environmental impacts.

This presentation aims to discuss approaches to how Pharmaceutical Industry to become more sustainable and produce a carbon handprint, not a footprint.

-

Speaker:

Hanns-Christian Mahler, CEO, ten23 health

13:05-13:30 PM | Best Practice for Designing and Implementing Successful Take Back Schemes for Used Devices and Packaging

Regulations and changing customer expectations are redefining the need for pharmaceutical providers to take back used devices and packaging. These items are often made of materials not accepted in household recycling schemes. These changes drive the need to understand design for recyclability, collections and treatment and collaborations within and beyond the industry. In this session, we will explore:

 

- How Take-back Schemes can improve the End-of-Life Outcomes for Pharmaceutical Products and Packaging

- How Companies are Designing Innovative Schemes for their Products

- Best Practices and Lessons for Implementation
 

-

Speaker:

Ellen Struthers, Principal Consultant, Anthesis Group




Very impressive conference. My first time at PHARMAPACK Europe- an overall good experience and great networking opportunity. I had the opportunity to learn and see the products that interest me and my business up close, and the conference lectures were interesting, and supported the market trends I was aware of. Thank you!

Mindy Katz, Program Manager (business development), Q Core Medical Ltd.

News & Updates


Pharmapack Event formally given the go-ahead by French Government

Pharmapack Event formally given the go-ahead by French Government


Our Partners


PharmaTech.com

See all partners

Contact Us


Customer Service Team
Send an email

+31 20 245 5355

Visitor FAQ
Exhibitor FAQ

Caution - Exhibitors


Beware of unsolicited websites and companies.

Follow Us


Sustainability | Our efforts recognised

Pharmapack Europe is Powered by Renewable Energy

Pharmapack Europe is Powered by Renewable Energy

As a part of our continued commitment to the sustainability of our event, 100% of the electricity used within Paris Expo venue is generated from a renewable origin. 
To learn more about this please click here. 

ISO 20121 Certified Sustainable Event Management System

ISO 20121 Certified Sustainable Event Management System

Our event has also been successfully accredited with the prestigious ISO 20121 Standard for Sustainable Event Management.

To learn more about this please click here. 

Pharmapack Europe is committed to Sustainability

Pharmapack Europe is committed to Sustainability

Running Pharmapack Europe gives us lots of opportunities to improve our impacts socially, environmentally, and economically in our host city.

We want to make a difference, and here’s how we do it. 

Informa Markets

Copyright © 2023. All rights reserved. Informa Markets, a trading division of Informa PLC.

  • Accessibility|
  • Privacy Policy |
  • Cookie Policy|
  • Terms of Use|
  • Visitor Terms And Conditions